RB1 and small cell lung carcinoma: However, our work highlights the importance of comprehensive histopathologic and molecular characterization of SCLC tumors subtyped in clinical cohorts, with particular focus on excluding potential SCLC mimics for tumors that lack neuroendocrine marker expression or have an unusual molecular background, for example retained expression of wild-type RB.